OrbiMed is an investment manager specializing in the healthcare sector. They manage investments for U.S. private funds and non-U.S. public and private funds, focusing on pharmaceutical, biotechnology, medical device, and healthcare service companies globally. OrbiMed's investment strategies are speculative and involve substantial risks, and there is no guarantee that investment objectives will be achieved.
Fee Structure
OrbiMed's fees vary among clients and are set separately with each client. They typically charge a percentage of the net assets they manage. These fees generally do not exceed 2% for public fund clients and 2.5% for private fund clients. Fees are typically payable in arrears based on the average monthly or quarterly net assets of the client’s account. OrbiMed also receives performance-based compensation.